论文部分内容阅读
异基因外周血造血干细胞移植（Allo－PBSCT）为继异基因骨髓移植（Allo－BMT）之后治疗慢性粒细胞白血病（CML）的又一最新有效手段，目前国内外主要尚在HLA相合者之间进行。1997年我们施行HLA部分不相合异基因外周血于细胞移植1例获得成功，报告如下。1病例和方法1．互供者及
Allo-PBSCT (Allo-PBSCT) is another latest effective treatment for chronic myelogenous leukemia (CML) after allo-BMT. Currently, it is mainly among HLA-matched individuals at home and abroad. get on. In 1997, we successfully performed one case of HLA-incompatible allogeneic peripheral blood cell transplantation. The report is as follows. 1 Cases and Methods 1. Mutual donors and